# Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome

> **NCT02483351** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 60 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

- **OTHER:** Liberal Red Blood Cell Transfusion Strategy
- **OTHER:** Restrictive Red Blood Cell Transfusion Strategy

## Key facts

- **NCT ID:** NCT02483351
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02483351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02483351, "Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT02483351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*